Infectious Diseases (except HIV/AIDS)

  1. Mutations in the nonstructural proteins of SARS-CoV-2 may contribute to adverse clinical outcome in patients with COVID-19

    1. Takaya Ichikawa
    2. Shiho Torii
    3. Hikoyu Suzuki
    4. Akio Takada
    5. Satoshi Suzuki
    6. Masahide Nakajima
    7. Akihito Tampo
    8. Yasutaka Kakinoki

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Wastewater-Based Epidemiological Modeling for Continuous Surveillance of COVID-19 Outbreak

    1. Mehrdad Fazli
    2. Samuel Sklar
    3. Michael D. Porter
    4. Brent A. French
    5. Heman Shakeri

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Homologous and Heterologous Covid-19 Booster Vaccinations

    1. Robert L. Atmar
    2. Kirsten E. Lyke
    3. Meagan E. Deming
    4. Lisa A. Jackson
    5. Angela R. Branche
    6. Hana M. El Sahly
    7. Christina A. Rostad
    8. Judith M. Martin
    9. Christine Johnston
    10. Richard E. Rupp
    11. Mark J. Mulligan
    12. Rebecca C. Brady
    13. Robert W. Frenck
    14. Martín Bäcker
    15. Angelica C. Kottkamp
    16. Tara M. Babu
    17. Kumaravel Rajakumar
    18. Srilatha Edupuganti
    19. David Dobrzynski
    20. Rhea N. Coler
    21. Christine M. Posavad
    22. Janet I. Archer
    23. Sonja Crandon
    24. Seema U. Nayak
    25. Daniel Szydlo
    26. Jillian A. Zemanek
    27. Clara P. Dominguez Islas
    28. Elizabeth R. Brown
    29. Mehul S. Suthar
    30. M. Juliana McElrath
    31. Adrian B. McDermott
    32. Sarah E. O’Connell
    33. David C. Montefiori
    34. Amanda Eaton
    35. Kathleen M. Neuzil
    36. David S. Stephens
    37. Paul C. Roberts
    38. John H. Beigel

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. A thermostable Cas12b from Brevibacillus leverages one-pot discrimination of SARS-CoV-2 variants of concern

    1. Long T. Nguyen
    2. Nicolas C. Macaluso
    3. Brianna L.M. Pizzano
    4. Melanie N. Cash
    5. Jan Spacek
    6. Jan Karasek
    7. Megan R. Miller
    8. John A. Lednicky
    9. Rhoel R. Dinglasan
    10. Marco Salemi
    11. Piyush K. Jain

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Long-term predictions of humoral immunity after two doses of BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex

    1. Chapin S. Korosec
    2. Suzan Farhang-Sardroodi
    3. David W. Dick
    4. Samaneh Gholami
    5. Mohammad Sajjad Ghaemi
    6. Iain R. Moyles
    7. Morgan Craig
    8. Hsu Kiang Ooi
    9. Jane M. Heffernan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers

    1. Eric D. Laing
    2. Carol D. Weiss
    3. Emily C. Samuels
    4. Si’Ana A. Coggins
    5. Wei Wang
    6. Richard Wang
    7. Russell Vassell
    8. Spencer L. Sterling
    9. Marana S. Tso
    10. Tonia Conner
    11. Emilie Goguet
    12. Matthew Moser
    13. Belinda M. Jackson-Thompson
    14. Luca Illinik
    15. Julian Davies
    16. Orlando Ortega
    17. Edward Parmelee
    18. Monique Hollis-Perry
    19. Santina E. Maiolatesi
    20. Gregory Wang
    21. Kathleen F. Ramsey
    22. Anatalio E. Reyes
    23. Yolanda Alcorta
    24. Mimi A. Wong
    25. Alyssa R. Lindrose
    26. Christopher A. Duplessis
    27. David R. Tribble
    28. Allison M.W. Malloy
    29. Timothy H. Burgess
    30. Simon D. Pollett
    31. Cara H. Olsen
    32. Christopher C. Broder
    33. Edward Mitre

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time

    1. Sebastian Havervall
    2. Ulrika Marking
    3. Nina Greilert‐Norin
    4. Max Gordon
    5. Henry Ng
    6. Wanda Christ
    7. Mia Phillipson
    8. Peter Nilsson
    9. Sophia Hober
    10. Kim Blom
    11. Jonas Klingström
    12. Sara Mangsbo
    13. Mikael Åberg
    14. Charlotte Thålin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Predicting COVID-19 Vaccine Efficacy from Neutralizing Antibody Levels

    1. Majid R. Abedi
    2. Samuel Dixon
    3. Timothy Guyon
    4. Serene Hsu
    5. Aviva R. Jacobs
    6. Lakshmi Nair
    7. Robert Terbrueggen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Impact of adaptive natural killer cells, KLRC2 genotype and cytomegalovirus reactivation on late mortality in patients with severe COVID‐19 lung disease

    1. Sarita Rani Jaiswal
    2. Jaganath Arunachalam
    3. Ashutosh Bhardwaj
    4. Ashraf Saifullah
    5. Rohit Lakhchaura
    6. Mayank Soni
    7. Gitali Bhagawati
    8. Suparno Chakrabarti

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Evaluation of real-life use of Point-Of-Care Rapid Antigen TEsting for SARS-CoV-2 in schools (EPOCRATES)

    1. Ana C. Blanchard
    2. Marc Desforges
    3. Annie-Claude Labbé
    4. Cat Tuong Nguyen
    5. Yves Petit
    6. Dominic Besner
    7. Kate Zinszer
    8. Olivier Séguin
    9. Zineb Laghdir
    10. Kelsey Adams
    11. Marie-Ève Benoit
    12. Geneviève Leduc
    13. Jean Longtin
    14. Ioannis Ragoussis
    15. David L. Buckeridge
    16. Caroline Quach

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 279 of 716 Next